Company Overview

Khiron Life Sciences Corp. is a Canadian integrated medical cannabis product development company with its core operations in Colombia. Khiron combines leading international scientific expertise with branded product market entrance experience to address the unmet medical needs of over 620 million people in the Latin American market.

Project Overview


  • Colombia has a leading position in the production of flowers globally (roses, carnations, chrysanthemums). Established horticultural expertise provides the potential for high quality and efficient cannabis growth and phytochemical extraction
  • Colombian market has 5.0 million potential cannabis patients (source: Quantiles IMS)
  • Colombia has transformed into a stable environment with the signing of the 2016 Colombia peace accord
  • Country’s debt investment-grade rated by all three major rating agencies (Standard & Poor’s, Fitch, Moody’s).

Strategic Alliances

  • Colombia ideal market for clinical studies for specific indications
  • Utilization of knowhow and doctor/patient relationships from alliances with the leading medical organization in Colombia
  • Sourcing intellectual knowhow from leading Canadian and Israeli cannabis companies and professionals
  • Medical grade strains with associated patient data and standard operation procedures (SOPs)
  • Engaged with leading security company headed by former DEA agents to ensure highest global and domestic standards in site security

Cultivation and Extraction

  • 4.5 hectares of land secured in region with ideal year-round growing conditions (climate, soil quality, access to water)
  • Option to increase land package to 18 hectares capable of producing over 100 tonnes of cannabis annually
  • Developing land consistent with good agricultural practices (GAP)
  • Secure region with little to no history of illegal activity. Located in region with well establish military presence
  • Acquiring good manufacturing practice laboratory (GMP) for production of extracts


  • Developing a strong brand by leveraging scientific and product launch expertise within the region
  • Positioning as scientific experts focused on patient health to create brand loyalty
  • Focus on differentiating by being medically-validated and scientifically innovative
  • Doctor and patient outreach programs by providing information on medical cannabis through content marketing, public engagement, database development, online advertising, and social media

Plant to Patient

Khiron’s business model is focused on investing in medical and scientific R&D, developing high quality products, and obtaining medical validation to build doctor and patient brand loyalty.

  • Medical & Scientific R&D:
    • Colombian medical institution research partnerships for high prevalence indications.
  • Seed Selection:
    • Use of medically-validated cannabis strains.
    • Internal genetic work by trained agronomists.
  • Cultivation:
    • Internationally validated standard operating procedures (SOPs).
    • Long-term leases on organically cultivated agricultural land.
    • Initial 4.5 hectares with an option to increase to 18.0 hectares.
  • Product Development:
    • Sourcing good manufacturing practice laboratory (GMP) for production of extracts to ensure first-to-market strategy.
    • Consulting contracts to obtain medical product extract knowhow.
  • Doctor Engagement:
    • Sponsorship of white papers with Colombia’s top medical associations.
    • Conference sponsorships and digital communications to raise doctor awareness of medical cannabis.
  • Patient Distribution:
    • Develop friendly web-based information systems to raise patient awareness and build patient database.
    • Engagement with Health Service Providers to maximize patient access.


Alvaro Torres

Alvaro Torres

Chief Executive Officer & Cofounder
  • Over 15 year of experience in Colombian infrastructure projects and project finance, management leadership and strategy, engineering, and mergers and acquisitions.
  • Grew SNC-Lavalin, Colombia from inception to ~2,000 person corporation.
  • Led growth strategies for engineering projects of over $1.0 billion in capital expenditure.
  • BEng, MEng, Rensselaer Polythecnic Institute & MBa, Georgetown University.
Andres Galofre

Andres Galofre

Chief Commercial Officer & Cofounder
  • Over 15 year of experience in pharmaceutical marketing and brand management.
  • Established distribution channels for ethical drugs and consumer products.
  • P&G, Kimberly-Clark, Pfizer product brand management. Led Advil launch in Colombia: product rose to 28% of domestic sales.
  • Managed business units with annuales sales $100 million.
  • MBA, La Trobe University & BBA, CESA.
Darren Collins

Darren Collins

Chief Finance Officer
  • Over 12 years of experience in finance and capital markets with investment firms and public issuers.
  • Involved in over a billion dollars of transactions involving emerging companies, including mergers and acquisitions, debt and equity financings, and joint venture partnerships.
  • Public issuer experience includes corporate governance, financial management and budgeting, and public listings.
  • BComm in finance, Dalhousie University
Juan Diego Alvarez

Juan Diego Alvarez

Chief Regulatory Officer
  • Professor of Law, Universidad de Los Andes since 2008. Over 10 years of legal experience.
  • Authority in Colombian medical cannabis regulation.
  • LLM, Columbia University, JD, Tulane University & LLB, Universidad de Los Andes. PhD law candidate.
Ana Maria Borda

Ana Maria Borda - PHD

Cultivation & Research Manager
  • Over 15 year of agricultural experience in Colombia and elsewhere in South America. In-depth knowledge of regional growing conditions.
  • Expert in the areas of biology, chemistry of biological systems, biochemistry, floriculture production and business, and packaging science.
  • PhD in horticultural science, University of Florida, MSc in agricultural studies, University of Queensland, BSc in biology, Los Andes University.
Paulo Vega

Paulo Vega - MD

Chief Medical Officer
  • Over 25 years experience as a neurologist.
  • Advisor to pharmaceutical sector businesses in drug and related business development. Officer for multinational and domestic pharmaceutical corporations.
  • Expertise in leading MD engagement, drug development and pharmaceutical product growth. Specific experience in validation studies approval process at INVIMA.
  • MD, University of Rosario & MBA, Deusto Business School.

Board of Directors

Sidney Himmel

Sidney Himmel

Chairman of the Board
  • Over 30 years of corporate experience in capital markets. Expert in project development, board governance, and finance.
  • Executive and director of public companies, and senior coporate finance, institutional sales and research experience with notable investment banks including Merill Lynch Canada Inc., and TD Securities.
  • BSc (Chemistry), University of Toronto & BA (Finance), University of Toronto. Received the Chartered Accountant designation in 1981.
Mark Monaghan

Mark Monaghan

  • Over 25 years investment banking and merchant banking experience as advisor, founder and board member.
  • Previously partner/senior executive of UK and Canadian investment and advisory firms. Currently Managing Partner of Panama based Dalvay Capital Corp, an investment and advisory firm focused on LATAM growth opportunities. Integral in completing billion-plus worth of capital raises and M&A transactions as principal, board member or advisor.
  • BA (Economics), Queen's University & BComm, University of Windsor.
Peter Simeon

Peter Simeon

  • Over 15 years of experience in corporate, commercial, and securities law.
  • Partner in Gowling WLG's Toronto office. Focuses his practice on corporate finance, mergers and acquisitions, and structured products.
  • Works closely with issuers, underwriters, and other corporate clients. Extensive experience working with cannabis focused issuers.
  • BA (Political Studies), Queen's University & LLB, Osgoode Hall.
Alvaro Yañez

Alvaro Yañez

  • Over 15 years of commercial and legal experience in Colombia and internationally.
  • Currently legal Manager of Pacific Exploration and Production, a Canadian oil company, considered on the most important independent oil companies in Latin America. Formerly with legal firms including Yañez & Asociados and in Arrieta, Mantilla & Asociados.
  • Universidad del Rosario, LLM in corporate law, Instituto de Empresa.

Advisory Board

Daniel Petrov

Daniel Petrov

  • Has founded a number of succesful cannabis companies and most recently served as Executive Vice President at Aurora Cannabis Inc. (TSX: ACB) from prior to its listing onto the CSE until mid 2016
  • Over 10 years of experience as an entrepreneur focused on innovative concepts, technologies, and corporate strategy
  • Currently CEO of Aura Health Studio and former EVP/founder of Aurora Cannabis, a large Canadian licenced producer
  • BSc (Computer Science), University of Alberta
Matthew Murphy

Matthew Murphy

  • Over 25 years with the U.S. DEA. Served in various positions, including Head of Pharmaceutical Compliance, prior to founding the Pharma Compliance Group
  • International security expert in risk assessment and system development, law enforcement, brand protection, regulatory compliance, and training
  • Criminal Justice, Northeastern University & Masters (Education), University of Virginia
Danial Schecter

Danial Schecter

  • Recognized medical expert in the field of prescription cannabinoids and medical cannabis.
  • Founder of Cannabinoid Medical Clinic as the first referral only clinic in Ontario, Canada with 22 clinics that provide care to over 22,000 patients under the Marihuana for Medical Purposes Regulations (MMPR).
  • Completed a fellowship in Hospital Medicine and is an active hospitalist at the Royal Victoria Regional Health Centre in Barrie, Ontario.
Mauricio Lopez Obregón

Mauricio López Obregón

  • Over 30 years of experience in a number of businesses in Colombia.
  • Member of the Advisory Committee of the David Rockerfeller Center for Latin American Studies at Harvard.
  • Former Board of Directors of the Fullbright Commission in Colombia, the University of Virginia Families Board, the Parents Committee at the University of Virginia, and former President of MIT Harvard Club de Colombia.
  • Member of Laspau's Executive Committee.
Adam Potts

Adam Potts

  • Over 15 years of experience in pharmaceutical sales, including the last 4 years spent devising market development and sales strategies for medical cannabis.
  • Former medical sales executive at one of Canada's leading licenced producers of medical cannabis. Experience also includes sales roles training at Pfizer, Bayer, and Xerox.
  • Active Volunteer with Camp Oochigeas, a summer camp for children with cancer.
  • BSc, Queen's University.
Nubia Martinez

Nubia Martinez

  • Over 25 years of experience in international business development and sponsorship.
  • Formerly President of Procolombia, Colombia's import-export agency, positioning Colombia as the hub for industrial and tourist development.
  • Strong Colombian institutional public and private sector experience in project and commercial development.
  • Strong government and regulatory relationships.